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Abstract 
 
Iron is an essential nutrient for every living cells because of it role as molecule for 
transport of oxygen, as well as DNA synthesis through synthesis of ribonucleotide 
reductase. Iron deficiency anemia patients, especially pregnant women and children are 
more susceptible to infection because of deterioration of their immune response. This was 
supported by findings of decreased in phagocytic activities of white blood cells and T-
cell lymphocyte proliferation impairment. Iron deficiency anemia (IDA) patients also 
affect working capacities hence diminishing working outcomes. Although the underlying 
mechanism of  immune defect in iron deficiency anemia is not clearly understood, 
multifactor events considered play their contributing roles such as abnormality of 
ribonucleotide reductase enzym, impairment of T-cell proliferation and activities, altered 
cytokine production of IL-2 and  IFNγ. 
The study was done to asses the relationship of IL-2 and gamma IFN with 
infection in IDA patients on lymphocyte culture supernatant of IDA patients. Study was 
conducted on cross-sectional analytic design. Sixty-four iron deficiency anemia patients 
treated in Sanglah General Teaching Hospital were recruited, and 31 (48.4%) out of 64 
IDA patients were man and 33 (51.6%) women, have been selected for the study. This 
study found 17 (26.7%) IDA patients with infection, aged 38 ± 14.48 years and 47 
(73.3%) IDA patients without infection, with age average of 40.5 ± 14.4 years. All 
variables of data characteristics examined did not indicate any statistical significant 
difference between group of IDA patients with infection and those without infection. The 
average level of hemoglobin between the two groups did not differ statistically. Similar 
result was obtained if samples were differentiated into severe (Hb< 7g/dl) and mild 
anemia. The study also revealed that there were no differences of cytokine level observed 
between older and younger age (upper and below 44.5 years) in IDA patients with 
infection and without infection. Furthermore, no differences of cytokine level were found 
based on gender between IDA male 10.9 (8.60 – 12,65) (pg/l) patients and IDA female 
patients 10.6 (7.50 – 13.43) (pg/l) with Z -0.490, p =0.624. Nevertheless, significant 
differences were noted between supernatant of IL-2 and IFNγ in IDA patients with 
infection when compared to IDA patients without infection (Z= - 2.509, p= 0.012 for 
supernatant IL-2; and Z= -2.569, p= 0.010 for supernatant  IFNγ).  
The study conclusion is that level of IL-2 and IFNγ from lymphocyte culture 
supernatant of patient suffered from IDA with infection is significantly lower when 
compared to IDA patient without infection. It therefore summarized that lower level of 
IL-2 and gamma IFN in patients suffered from iron deficiency impaired their immune 
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response to certain infections therefore this findings support the theory that IDA patients 
more susceptible to get infected. 
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Introduction 
 
Iron deficiency anemia (IDA) is 
anemia caused by decreased level of iron 
in the body resulting in depleted iron 
reserve that is not sufficient for normal 
erythropoesis process. The most 
common cause of IDA is deficiency iron 
loss due to chronic bleeding.  
Study of etiology of iron 
deficiency anemia for 3,5 years on 122 
IDA patients revealed that 
ankylostomiasis, hemorrhoid, peptic 
ulcer and malignancy as a prominent 
causes. The study carried out in 2003 at 
Sanglah Hospital/Department of Internal 
Medicine, 14% of IDA cases were found 
with infections.1 Iron deficiency can lead 
to increase morbidity especially for 
babies and pregnant woman due to 
impairment of immune response such as 
decreased killing activities of neutrophil, 
defect in T cell proliferation.2,3 
The relation of iron deficiency 
with infections is difficult to study in 
humans, either by observational or non-
interventional studies. As such, studies 
on the relation of IDA with infections 
tend to give inconsistent results. Several 
observational studies done on human 
subjects showed increase of infection 
cases in the subjects with IDA. On the 
contrary, other studies have found 
opposite results in which iron deficiency 
was even protective against infections.4,5 
Many other studies on humans 
and experimental animals have shown 
significant decrease of the levels of 
certain cytokines in iron deficiency state. 
The study by Bergman et al.6 on adult 
subjects with IDA showed a lower level 
of IL-2 than in normal subjects, but the 
levels of other cytokines such as IL-6, 
IL-10, and TNFα were not significantly 
different from those of normal subjects. 
A study in Malawi, Africa found IDA 
was associated with lower production of 
IFNγ and IL-8 as compared with 
subjects having normal iron state. In this 
study a strong correlation was also found 
between IDA and the level of IL6-
producing lymphocytes.7 Similarly, 
another study done in Paris on 53 
patients with IDA and 28 controls with 
normal iron state found significant 
different levels of IL-2 in the two 
groups.8  
A study on mice with IDA 
carried out by Kuvibidilla et al.9 showed 
a decrease of IFN γ and IL-12 by  64% 
and 66% respectively, in which the level 
of these cytokines had positive 
correlation with iron status indicator 
(r=0.68). Another researcher proved that 
suppressed production of IFN γ in mice 
with lipo-polysaccharide tolerance 
caused macrophages dysfunction that 
subsequently impaired cellular 
immunity.10 According to the above 
findings, it is understandable that the 
relation between pro-inflammation 
interleukin and iron deficiency remains 
unclear. The production of IL-2 and IFN 
γ as pro-inflammation interleukin and 
CMI parameters is assumed to decrease 
in IDA cases. Based on that, it is 
necessary to carry out a study to assess 
the level of IL-2 and IFN γ in human 
IDA patients.    
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Materials and Methods 
 This study was carried out using 
descriptive analytical cross sectional 
study to find out the mean difference of 
IL-2 and IFN γ levels in both IDA 
patients with infection and those without 
infection. The accessible population was 
all IDA patients who visited the Sanglah 
Hospital and several doctors’ private 
practices in Denpasar. The study 
subjects were patients with IDA 
(intended samples) selected from the 
accessible population that met the 
inclusion and exclusion criteria by using 
consecutive sampling technique. The 
actual study subjects were patients with 
IDA who had confirmed to involve in 
this study by signing an informed 
consent.  The criteria for IDA using 
combination of hypochromic –
microcyter anemia with level of ferritin 
serum less than 20 ug/l. Exclusion 
criteria of study were: patients who 
suffered from protein energy 
malnutrition, patients who received 
immunosuppressive medicine, such as 
steroid and chemotherapy, minimum in 
the last one month, patients with renal 
failure, genetic disorders, and 
malignancies, patients who did not 
consent to involve in the study. Patients 
who finally consent to join the study 
were informed about the study aims. 
Materials of the study consisted of 
supernatant of lymphocytes culture for 
IL-2 and IFN γ concentrations 
examination as well as list of 
questionnaires for obtaining data on age, 
gender, body weight, infections suffered, 
use of immunosuppressive medicines, 
malnutrition, malignancy and genetic 
disorder, and IDA diagnosis.   
  All collected data were first 
assessed before taken for analysis. The 
normality test of Kolmogorov-Smirnov  
(Shapiro-Wilk for small samples) was 
done to assess whether the data were 
normally distributed or not. Descriptive 
statistics was used to illustrate patient’s 
characteristics and frequency 
distribution of various variables. U 
Mann-Whitney test was used to evaluate 
the average difference of IL-2 and IFN γ 
concentrations in IDA with and without 
infection. The above statistic analysis 
used p < 0.05 as the significance 
standard, by means of statistic software 
SPSS for window version 15.0 .  
 
Results 
 
There were 64 IDA patients in 
this study, 31 patients males (48.4%) and 
33 females (51.6%) with age average of 
40.5 ± 14.4 years. A number of 17 
(26.7%) were IDA patients with 
infection and the remainder 47 (73.3%) 
were without infection. Type of infection 
mostly lung infection then followed by 
urinary infection, gastroenteritis and 
viral disease. All variables of data 
characteristics examined did not indicate 
any statistical significant difference 
between group of IDA patients with 
infection and those without infection. 
The average level of hemoglobin 
between the two groups did not differ 
statistically. Similar result was obtained 
if samples were differentiated into 
severe (Hb< 7g/dl) and mild anemia. 
Basic characteristics of IDA patients 
according to presence of infection are 
described in table 1.    
     Based on gender there were no 
significant differences showed between 
IDA male patients and IDA female 
patients as shown on table 2. 
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Table 1 Basic Characteristics of IDA Patient 
 
Characteristics  IDA with Infection Means ± SD 
IDA without 
Infection 
Means ± SD 
P value 
Age (years) 38±14.48 41±14.54 0.59 
Sex (M/F) 8/9 23/24 0.89 
Leukocyte (K/µl) 9.7±3.91 8.0±3.66 0.17 
Hemoglobine (g/dl) 6.5±1.82 6.6±1.91 0.81 
MCV (fl) 65.8±7.81 81.9±8.65 0.95 
MCH (pg) 19.3±2.57 19.2±4.06 0.88 
MCHC (%) 29.1±1.78 28.0±4.10 0.58 
Thrombocyte (K/µl) 400.7±132.40 418.5±178.6 0.73 
SI (µg/l) 12.1±3.95 13.5±7.18 0.34 
Transferin Saturation  (%) 4.28±1.90 3.51±2.03 0.22 
Ferritin (µg/l) 10.5±8.26 8.6±7.50 0.39 
AST (IU/l) 22.2±10.10 23.14±8.23 0.81 
ALT (IU/l) 16.0±11.10 18.6±10.3 0.59 
BUN (mg/dl) 10.7±4.84 16.2±6.46 0.05 
SC (mg/dl) 0.99±0.20 0.78±0.31 0.07 
 
          
Tabel 2 
Profile of cytokine of Iron Deficiency Anemia (IDA) patients based on gender 
 
Iron Deficiency anemia 
Cytokine Male 
(n=31) 
Median 
(Interquartile) 
Female 
(n=33) 
Median 
(Interquartile) 
Z value P value 
Supernatan IL-2 
(pg/l) 
10.9 
(8.60 – 12.65) 
10.6 
(7.50 – 13.43) -0.490 0.624 
Supernatan IFNγ 
(pg/l) 
26.3 
(14.50 –43.00) 
31.3 
(17.50 –43.50) -0.336 0.707 
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Tabel 3 
Profile of cytokine of Iron Deficiency Anemia (IDA) patients based on median ages. 
 
Iron Deficiency anemia 
Cytokine  Age < 44.5  
(n=39) 
Median 
Interquartile 
Age > 44.5  
(n=25) 
Median 
Interquartile 
Z value P value 
Supernatan IL-2 
(pg/l) 
10.5  
(9.5-13.4) 
11.2 
 (7.9-13.1) -0.186 0.85 
Supernatan IFNγ 
(pg/l) 
39.0  
(21.3-48.3) 
19.8  
(2.2-40.3) -2.408 0.06 
  
 
  
 
Table 4. 
Difference of Median Interquartile of Cytokine of Supernatant  
between IDA Patient with Infection and IDA Patient without Infection 
Iron Deficiency Anemia 
Supernatant 
Cytokine With Infection 
(n=17) 
Median Interquartile
With Infection 
(n=17) 
Median Interquartile 
Z value P value 
Interleukin-2 
(pg/l) 
9.7  
(7.90–11.10) 
11.4  
(9.80–14.30) - 2.509 0.012 
 IFNγ (pg/l) 20.4  (11.20–30.45) 
39.2  
(18.80–48.30) - 2.569 0.010 
 
As we aware of, old ages influence 
immune response as well as cytokine 
production. But on table 3 can be seen 
that there were no differences of 
cytokine level observed between older 
and younger age (upper and below 44.5 
years). 
 Statistic test applied was the 
non-parametric one because the non-
normal distribution of IL-2 and IFNγ 
considering that Kolmogorov Smirnov 
test gave insignificant results (IL-2 Z= 
3.320; p<0.001 and IFNγ Z= 2.857; 
p<0.001) and still did not distribute 
normally even though a logarithm 
transformation has been applied to both 
variables. Hence, non parametric test of 
Mann Whitney U was used since this 
test was accurate as a substitute for other 
inadequate parametric tests that did not 
meet analysis requirements due to 
efficiency capacity close to 95% with an 
increase of n value.  
6 
The cytokine concentration difference 
examined from supernatant lymphocytes 
culture (Mann Whitney U test) of IDA 
group without infection is shown on 
table 4.3. It showed that IL-2 and IFNγ 
concentrations of the two groups were 
statistically significant difference with 
Z= -2.509 ; p= 0.012 and Z= -2.569 ; p= 
0.010 respectively. 
 
Discussion 
 
Diagnosis of Iron Deficiency Anemia 
Basically the diagnosis procedures 
of iron deficiency anemia consist of 
three components: (1) diagnosis of the 
anemia; (2) diagnosis of the iron 
deficiency, and (3) determination of the 
etiologic factors of the iron 
deficiency.11,12 Staining of iron contained 
in bone marrow aspirate by the Prussian 
blue or Pearls’ staining method 
comprises a diagnostic measure to 
determine the body’s iron depot. 
Absence of stained iron as hemosiderin 
dots in cytoplasm of reticuloendothelial 
cells confirms the existence of iron 
deficiency, with no other lab 
examinations required.13 However, 
examination of bone marrow’s iron is a 
highly inpractical and invasive 
procedure; thus causing most patients 
tend to reject it.  
 In this study the diagnosis of 
iron deficiency anemia was based on 
finding of hypochromic, microcytic red 
blood cells and ferritin serum level < 20 
ug/l. According to the National Health 
and Nutrition Evaluation Survey II, the 
use of two or more indicators of the iron 
status is highly recommended for the 
diagnosis of iron deficiency anemia.  
This study also noted that single low 
serum ferritin level comprised one 
important indicator for the diagnosis of 
iron deficiency anemia, besides iron 
depleted state.14 A correlation exists 
between the level of serum ferritin and 
the level of body’s iron reserve; thus 
iron deficiency is the only cause of low 
level of serum ferritin.11,15,16 The 
weakness of serum ferritin examination 
for the diagnosis of iron deficiency 
anemia exists in the fact that the level of 
serum ferritin increases in infectious 
diseases, chronic inflammations, 
malignancies, and certain liver diseases. 
In spite of such conditions, however, the 
correlation of serum ferritin level with 
body’s iron reserve still exists, though 
consequently with a higher value. The 
level of serum ferritin still has its high 
diagnostic value in the confirmation of 
iron deficiency anemia, provided the 
above abnormal conditions are taken 
into account in making interpretation.  
However, using serum ferritin level as a 
single indicator for diagnosis of iron 
deficiency anemia in the tropical areas 
tends to give such a result categorized as 
under estimate, due to several 
compounding factors. Hence, the use of 
combined several parameters is highly 
recommended.17 
 
Iron Deficiency Anemia and Infections  
 In this study iron deficiency 
anemia with concomitant infections was 
found in 17 subjects (26.7%) of 64 
patients with confirmed IDA. In 2006, 
according to patient records in the 
Division of Hematology and Medical 
Oncology of the Department of Internal 
Medicine, Sanglah Hospital, 21 of 78 
IDA patients were with infections. In a 
previous study carried out in 2003 at 
Sanglah Hospital/Department of Internal 
Medicine, 14% of IDA cases were found 
with infections.1 In Malawi, Africa 26% 
of IDA cases was found with HIV, 24% 
with bacterial infections, and 20% with 
malaria.7 Another study done in Israel on 
7 
680 IDA patients found a total of 5644 
episodes of acute ear infections with an 
average of 8.3 episodes per patient; and 
77.6% among 528 patients had 
simultaneous infections in both ears.18 
 The relation of iron deficiency 
with infections is difficult to study in 
humans, either by observational or non-
interventional studies. In fact, iron 
deficiency can be regarded as a form of 
malnourishment that exists as 
intertwined social and health problems 
resulted from poverty. Moreover, it is 
against ethical consideration to delay 
administration of iron preparation to 
patients with IDA because this may 
worsen the patients’ condition. As such, 
studies on the relation of IDA with 
infections tend to give inconsistent 
results.5 
 Several observational studies 
done on human subjects showed increase 
of infection cases in the subjects with 
IDA. A study, considered a pioneer of its 
kind until now, was done in London in 
1928 to observe the effects of IDA on 
infection episodes. In this study it was 
found that about half of 541 subjects 
studied had significant lower episodes of 
infections in the group given iron 
preparation. Another study involving a 
greater number of subjects was done in 
Chicago in 1966 where more than 1000 
babies with IDA were studied; the result 
showed a significant lower number of 
upper respiratory tract infections in those 
babies given iron preparation.19 Higgs 
dan Wells20 studied 31 patients with 
chronic musculocutaneous candidiasis, 
of which 23 had IDA, and found that 9 
among 11 patients got better outcome 
after given iron preparation. A 
prospective clinical study on postsurgery 
patients showed a significant greater 
number of infection cases among those 
having low level of serum ferritin (228 
cases) as compared with those (220 
cases) who had normal level of serum 
ferritin.5  
A study in Chile on 100 babies of 
which half of the babies given formula 
food containing iron while the other half 
were given formula food without iron. 
Morbidity data of the babies were 
recorded during weekly home visits.  It 
was found that 30% of the babies given 
food without iron experienced illnesses, 
in contrast to only 5% of the babies 
given food with iron. No significant 
difference was noted between respiratory 
tract infection and gastrointestinal 
infection cases in the two groups; 
however, there might possibly be a slight 
difference as there were only 2 cases of 
anemia among 53 babies given iron-
containing formula food, while there 
were 14 anemia cases among 47 babies 
given food without iron.21 
 On the contrary, other studies 
have found opposite results in which 
iron deficiency was even protective 
against infections.   A study in Somalia, 
which has been very much cited, showed 
that iron deficiency state was even 
beneficial to the patients.   In this study, 
randomly selected 137 adult patients 
with IDA were divided into two groups 
who were given iron and placebo tablets, 
respectively, for one month. In the group 
given iron (N = 66) 36 subjects 
experienced infection episodes as 
compared with only 3 subjects of the 
placebo group (N = 71) who experienced 
infection episodes. Although much 
criticized for its short time provided for 
follow-up and lack of double blinded 
approach, this study has proven that in a 
certain state iron administration may 
cause increase of certain infection 
episodes.4 Another study by 
Oppenheimer in Papua New Guinea has 
shown that low level of serum iron in 
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babies protected them from getting 
malaria. The finding that low level of 
serum iron could protect the babies from 
malaria may be explained from the 
aspect that malaria parasites need iron of 
erythrocytes for completion of their life 
cycles.22 
 Different from the above two 
studies were a few other studies that 
found iron status had no influence on the 
susceptibility to infections. A study in 
Tanzania involving 800 babies who were 
given iron supplement for 24 weeks 
found no increase of malaria cases, but 
other types of infections were not 
recorded.  A study in Chile found a 
similar result; administration of fortified 
iron preparation to babies up to one year 
of age did not result in increase of 
diarrhea or upper respiratory tract 
infections.  However, it was found that 
infection cases occurred more frequently 
among babies with iron deficiency than 
those with normal iron status.21 
 Many studies on humans and 
animals have shown the presence of 
disorders of the cellular immunity and 
other nonspecific immunities in subjects 
with iron deficiency, but the relation of 
iron deficiency with infection remains 
unclear. Susceptibility to infections 
comprises a complex mechanism; it does 
not depend on one’s iron status alone but 
also on other factors such as body 
condition, types of 
parasites/microorganisms, and 
environment. Among the other 
influencing factors are exposure to 
microorganisms, other nutritional 
deficiency, types of population (babies, 
children, females, males, elderly), 
duration and severity of the deficiency, 
type, dosage, and duration of iron 
therapy, and existence of other 
preconditional factors.  It is clear that 
these concomitant factors greatly 
influence the degree of susceptibility to 
and severity of infections, regardless of 
the level of iron status.  Iron deficiency 
influences susceptibity to certain types 
of infection, and duration and severity of 
the infections depend on the body 
condition and types of parasites, either 
extra or intra cellular microorganisms.23 
Results of our study seem to 
agree with the theory that patients with 
IDA are prone to infections, as indicated 
by the finding of significant lower level 
of  plasma and supernatant IL-2 and 
IFNγ in IDA patients with concomitant 
infections as compared with those 
without infections (p<0.05). As a 
response to infection, the body must 
activate its immunity mechanism, either 
natural or adaptive ones. For developing 
an optimal immunity response, 
especially the cellular immunity 
response, the body produces and 
activates the cytokines IL-2 and IFN γ. 
Our study results also agree with 
that of a study done in China where 63 
IDA patients with recurrent upper 
respiratory tract infections were 
examined for their levels of IL-2 and 
sIL-2R as well as for their subset 
lymphocyte T cells. In the latter study it 
was found that activation of IL-2 and 
percentage of CD3 and CD4 were 
significantly lower in children suffering 
from IDA with repeated upper 
respiratory infections as compared with 
a healthy control group.24 
Many other studies on humans 
and experimental animals have shown 
significant decrease of the levels of 
certain cytokines in iron deficiency state. 
The study by Bergman et al. on adult 
subjects with IDA showed a lower level 
of IL-2 than in normal subjects, but the 
levels of other cytokines such as IL-6, 
IL-10, and TNFα were not significantly 
different from those of normal subjects.6 
9 
A study in Malawi, Africa found IDA 
was associated with lower production of 
IFNγ and IL-8 as compared with 
subjects having normal iron state. In this 
study a strong correlation was also found 
between IDA and the level of IL6-
producing lymphocytes.7 Similarly, 
another study done in Paris on 53 
patients with IDA and 28 controls with 
normal iron state found significant 
different levels of IL-2 in the two 
groups.8 An experimental study on iron 
deficient made animals also showed a 
lower level of IL-2.25 Kuvibidila in his 
study on mice that were made iron 
deficient found a lower level of IL-
12p40 and IFNγ in the group of mice 
with iron deficiency as compared with 
those mice given rations with normal 
iron supplement (p< 0.05). There was a 
positive correlation between the levels of 
cytokines and indicators of iron state (r 
0,688, p= <0.05).9 A similar result was 
also found in a controlled study on 
children in which a lower secretion of 
IL-2 was noted in children with iron 
deficiency as compared with the healthy 
control group.26 
The mechanism of how iron 
deficiency can disturb cellular and 
nonspecific immunity responses is not 
yet clearly understood, but it is thought 
to be due to multifactorial features.  
These include decrease of activity of 
enzymes containing iron such as  
ribonucleotide reductase, 
myeloperoxidase, decrease of cytokines 
production, decrease of competent  T 
cells, and probably disturbance of 
signals transduction. The exact phase of 
disturbance of signal transduction where 
iron plays a part is yet to be clarified, 
although previous studies have 
confirmed the influence of the 
disturbance in the activity of protein 
kinase C and its translocation on the 
plasma cells membrane and T cells of 
the spleen. These findings were seen in 
both human and animal study subjects. It 
is also known that binding of iron causes 
decreased production of mRNA needed 
for development of protein kinase C.27 In 
the initial stage of T cells activation, 
disturbance occurs in the hydrolysis of  
phosphatidylinositol 4,5-bisphosphate 
(PIP2) by phospolipase C (an enzyme 
containing zinc), with its final result as 
inositol 1,3,5-triphophate (IP3) and 
diacylglycerol (DAG), which regulate 
activity of protein kinase C. Both protein 
kinase C and hydrolysis of phospholipid 
membrane are important for the initial 
process of transduction signal that can 
cause proliferation of T cells and 
activation of other functions. Thus, 
disturbance of protein kinase C and 
hydrolysis of phospholipid membrane 
result in disturbance of immune response 
in subjects with iron deficiency.28 
 
Conclusions  
 From results and discussion 
described above, it can be concluded that 
concentration of IL-2 and IFN γ  in 
supernatant of lymphocytes culture was 
significantly lower in IDA patients with 
infection than those without infection. 
Therefore IDA patients were more 
susceptible to certain infection because 
of impaired immune response due to low 
level of IL-2 and IFN γ.   
 
References 
 
1. Suega K, Sajinadiyasa, Dharma 
yuda TG, Bakta IM. Gambaran 
etiologi anemia defisiensi besi di 
Bagian Ilmu Penyakit Dalam 
Rumah Sakit Sanglah Denpasar. 
Majalah Penyakit Dalam Udayana 
2003; 3(1):51-5. 
10 
2. Ekiz C, Agaoglu L, Karakas Z, 
Gurel N, Yalcin I. The effect of 
iron deficiency anemia on the 
function of the immune system. 
The Hematology Journal 2005; 
5:579-83. 
3. Mullick S, Rusia U, Sikka M, 
Faridi MA. Impact of iron 
deficiency anaemia on T 
lymphocytes & their subsets in 
children. Indian J Med Res 
2006;124:647- 54. 
4. Walter T, Olivares M, Pizarro F, 
Munos C. Iron, anemia, and infec 
tion. Nutritional review 1997;55 
(4):111-24. 
5. Oppenheimer SJ. Iron and its 
relation to immunity and infectious 
disease. J Nutr 2001;131:616S-
35S. 
6. Bergman M, Bessler H, Salman H, 
Siomin D, Straussberg R, Djaldetti 
M. In vitro cytokine production in 
patients with iron deficiency 
anemia. Clinical Immunology 
2004;113:340-4. 
7. Jason J, Archibald LK, 
Nwanyanwu OC, Bell M, Jensen J, 
Gunter E. The effect of iron 
defeciency on lymphocyte cytokine 
production and activation: 
preservation of hepatic iron but not 
all cost. Clin Exp Immunol 
2001;126:466-73. 
8. Galan P, Thibault H, Preziosi P, 
Hercberg S. Interleukin 2 produc 
tion in iron-deficiency children. 
Biol Trace Elem Res 1992;32:421-
6. 
9. Kuvibidila S, Warrier RP. 
Differential effect of iron defi 
ciency and underfeeding on serum 
levels of interleukin-10, interleu 
kin-12p40, and interferon- γ in 
mice. Cytokine 2004; 26(2):73-81. 
10. Varma TK. Cellular mechanism 
that cause suppresed gamma 
interferon secretion in endotoxin-
tolerant mice. Infection and 
Immunity 2001;6:5249- 63.  
11. Bakta IM. Pedoman diagnosis dan 
terapi hematologi. Denpasar: 
Divisi Hematologi dan Onkologi 
Medik Bag./SMF Penyakit Dalam 
FK UNUD/RSUP; 2000. p. 1-4. 
12. Lee GR. Iron deficiency and iron 
deficiency anemia. In: Lee GR, 
Bithell TC, Foester J, Athen JW, 
editors. Wintrobe`s clinical 
hematology. 10ed. Philadelphia: 
Lea & Febiber; 1999. p. 808-39.  
13. Conrad ME.  Iron deficiency 
anemia. Medicine Journal 2002; 
3:114-24. 
14. Herbert V, Jayatilleke E, Shaw S, 
Rosman AS, Giardina P, Grady 
RW. Stem Cells 1997;15:291-6. 
15. Skikne BS. Current concepts in 
iron deficiency anemia. Food Rev 
Int 1988;4:137-73. 
16. Frewin R, Henson A, Provan D. 
ABC of clinical haematology: iron 
deficiency anemia. BMJ 1997; 
2:314-60. 
17. Guyatt GH, Oxman AD, Ali M, 
Wilan A, Mcllroy W, Patterson C. 
Laboratory diagnosis of  iron 
deficiency anemia: an overview. J 
Gen Intern Med 1992;7:145-53. 
18. Golz A, Netzer A, Goldenberg D, 
Westerman ST, Westerman LM, 
Joachims HZ. Am J Otolaryngol 
2001;22:391-4. 
11 
19. Dallman PR. Iron deficiency and 
the immune response. Am J Clin 
Nutr 1987;46:329-34. 
20. Higgs JM, Wells RS. Chronic 
muco-cutaneus candidiasis: new 
approaches to treatment. Br. J. 
dermatol 1973;89:179-90. 
21. Heresi G, Pizarro F, Olivares M, 
Cayazzo M, Hertampg E, Walter 
T, et al. Effect of supplementation 
with iron-fortified milk on 
incidence of diarrhea and 
respiratory infection in urban-
resident infants. Scandinavian 
Journal of Infectious Disease 
1995;27:385-9. 
22. Oppenheimer SJ, Gibson FD, 
MacFarlane SB, Moody JB, 
Harrison C, Spencer A, et al. Iron 
supplementation increases 
prevalence and effects of malaria: 
report on clinical studies in Papua 
New Guinea. Transactions of the 
Royal Society of Tropical 
Medicine and Hygiene 
1986;80:603-12. 
23. Kuvibidila S, Baliga BS. Role of 
iron in immunity and infection. 
CAB International : Nutrition and 
Immune Function 2002:209-28. 
 
 
 
 
 
 
 
 
 
24. iu W, Jiang A, Guo C. Cellular 
immunity in children iron 
deficiency anemia with recurrent 
respiratory infections. Abstract. 
Zhonghua Xue Ye Xue Za Zhi 
1997;18(11):566-7. 
25. Latunde-Dada GO, Young SP. Iron 
deficiency and immune responses. 
Abstract. Scand J Imunol Suppl 
1992;11:207-9. 
26. Sipahi T, Akar N, Egin Y, Cin S. 
Serum interleukin-2 and 
interleukin-6 levels in iron 
deficiency anemia. Pediatr hematol 
Oncol 1998;15(1):69-73. 
27. Alcantara O, Obeid L, Hannu Y, 
Ponka P, Boldt DH. Regulation of 
protein kinase C (PKC) expression 
by iron: effect of different iron 
compounds on PKC-gene 
expression and the role of the 5´ 
flanking region of the PKC-gene in 
the response to ferric transferrin. 
Blood 1994;84:3510-7. 
28. Kuvibidila S, Warrier RP, Baliga 
BS. An overview of the role of iron 
in T cell activation. The Journal of 
Trace Elements in Experimental 
Medicine 2003;16:219-25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
